BioStock: Pharming completes bid for Abliva

Dutch Pharming Technologies has reached a 87.7 per cent ownership stake in Abliva, following through with its acquisition of the company. Originally expiring last week, the acceptance period has now been extended to give remaining shareholders the opportunity to accept the offer.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/02/pharming-completes-bid-for-abliva/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se